Form 4 Filing for C4 Therapeutics, Inc. - Cooper Ronald Harold Wilfred

This filing details a Form 4 submission by Cooper Ronald Harold Wilfred, a director at C4 Therapeutics, Inc. The transaction, dated June 24, 2026, involves the acquisition of 62,000 stock options with a right to buy common stock. The options have an exercise price of $4.25 and are set to expire on June 23, 2036. A footnote indicates that the options will vest and become exercisable on the earlier of June 24, 2027, or the next annual stockholder meeting, contingent upon continued service as a Board member. The filing also notes that this is a direct ownership transaction. The reporting owner, Cooper Ronald Harold Wilfred, is identified with CIK 0001676880, and the issuer is C4 Therapeutics, Inc. (CIK 0001662579) trading under the symbol CCCC.